The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link?

(1) Background: Uric acid is a well-known cardiovascular (CV) risk factor in the general population but its role in the setting of rheumatic diseases other than gout is unclear. (2) Methods: This is a retrospective study investigating a cohort of 105 pSS patients recording clinical, serological, and CV-related variables including adherence to the Mediterranean diet. (3) Results: We observed a strong relationship between disease activity, interstitial lung disease (ILD), and CV events. The association between ILD and CV events was dependent on higher SUA levels but independent of other traditional CV risk factors. All three cases of previous non-fatal stroke were reported by females aged <65 years, with higher SUA levels, and two of them also had pSS-ILD. Forty (38%) patients had a 10-year risk of fatal and non-fatal CV disease events beyond the cut-off recommended for their age, and using the correction factor of 1.5 currently applied only to rheumatoid arthritis, we could better identify patient subsets characterized by different CV risk profiles including different SUA levels. (4) Conclusions: This study is the first to investigate in depth the role of SUA in the CV scenario of pSS. Our findings underpin the importance of assessing SUA levels in pSS in addition to the other traditional CV risk factors and to consider applying the correction factor for CV risk assessment tools to achieve a better stratification of CV risk.

[1]  Yiwen Zhang,et al.  Relationship between serum uric acid and hypertension in patients with primary Sjögren's syndrome: A retrospective cohort study , 2022, Journal of clinical hypertension.

[2]  W. Cubała,et al.  Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2022, European journal of preventive cardiology.

[3]  Jianmin Xie,et al.  Serum Uric Acid as a Diagnostic Biomarker for Rheumatoid Arthritis–Associated Interstitial Lung Disease , 2022, Inflammation.

[4]  I. Bruce,et al.  EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome , 2022, Annals of the Rheumatic Diseases.

[5]  E. Bartoloni,et al.  Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome. , 2021, Clinical and experimental rheumatology.

[6]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[7]  W. Peng,et al.  The Relationship Between Elevated Serum Uric Acid and Risk of Stroke in Adult: An Updated and Dose–Response Meta-Analysis , 2021, Frontiers in Neurology.

[8]  Heung-Woo Park,et al.  Lung function decline is associated with serum uric acid in Korean health screening individuals , 2021, Scientific Reports.

[9]  Steffen E. Petersen,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2016, European journal of preventive cardiology.

[10]  F. Carubbi,et al.  Unmet needs in primary Sjögren's syndrome and the never-ending quest for the perfect biomarker. , 2020, Acta reumatologica portuguesa.

[11]  G. Parati,et al.  Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study , 2020, Journal of hypertension.

[12]  G. Parati,et al.  Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years , 2019, Hypertension.

[13]  D. van Schaardenburg,et al.  Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review , 2019, Nutrients.

[14]  C. Borghi,et al.  Hyperuricaemia and vascular risk: the debate continues. , 2019, Current opinion in cardiology.

[15]  T. Barnetche,et al.  Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta‐Analysis , 2020, Arthritis care & research.

[16]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[17]  L. Criswell,et al.  Primary Sjögren's Syndrome , 2018, The New England journal of medicine.

[18]  M. Givertz Treating Gout in Patients With Cardiovascular Disease: Mutual Benefit or Unintended Consequences? , 2018, Journal of the American College of Cardiology.

[19]  S. Bombardieri,et al.  Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome. , 2017, Clinical and experimental rheumatology.

[20]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.

[21]  O. D. Del Brutto,et al.  Dietary Oily Fish Intake and Blood Pressure Levels: A Population‐Based Study , 2016, Journal of clinical hypertension.

[22]  S. Pocock,et al.  VALIDATION OF A QUESTIONNAIRE TO MEASURE OVERALL MEDITERRANEAN LIFESTYLE HABITS FOR RESEARCH APPLICATION: THE MEDITERRANEAN LIFESTYLE INDEX (MEDLIFE). , 2015, Nutricion hospitalaria.

[23]  S. Bombardieri,et al.  Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study , 2015, Journal of internal medicine.

[24]  S. Bombardieri,et al.  A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome , 2015, Lupus.

[25]  F. Ciccia,et al.  Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study. , 2014, Seminars in arthritis and rheumatism.

[26]  L. Sechi,et al.  Fish meal supplementation and ambulatory blood pressure in patients with hypertension: relevance of baseline membrane fatty acid composition. , 2014, American journal of hypertension.

[27]  C. Chiang Primary Sjogren's syndrome and risk of ischemic stroke: a nationwide study , 2013 .

[28]  Dolores Corella,et al.  A 14-Item Mediterranean Diet Assessment Tool and Obesity Indexes among High-Risk Subjects: The PREDIMED Trial , 2012, PloS one.

[29]  P. Ravaud,et al.  EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome , 2011, Annals of the rheumatic diseases.

[30]  G. Baron,et al.  EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2009, Annals of the rheumatic diseases.

[31]  J. Tschopp,et al.  Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. , 2009, American journal of respiratory and critical care medicine.

[32]  Duk-Hee Kang,et al.  Uric acid and cardiovascular risk. , 2008, The New England journal of medicine.

[33]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[34]  Lesley Oakley,et al.  The Debate Continues … , 1985, Children Australia.